Versatile impact of serum proteins on ruthenium(II) polypyridyl complexes properties - Opportunities and obstacles

(E-pub Abstract Ahead of Print)

Author(s): Olga Mazuryk*, Przemysław Gajda-Morszewski, Małgorzata Brindell.

Journal Name: Current Protein & Peptide Science

Submit Manuscript
Submit Proposal


Ruthenium(II) polypyridyl complexes have been extensively studied for the past few decades as promising anticancer agents. Despite the expected intravenous route of administration, the interaction between Ru(II) polypyridyl compounds and serum proteins is not well characterized and vast majority of the available literature data concerns determination of the binding constant. Ru-protein adducts can modify the biological effects of the Ru complexes influencing their cytotoxic and antimicrobial activity as well as introduce significant changes in their photophysical properties. More extensive research on the interaction between serum proteins and Ru(II) polypyridyl complexes is important for further development of Ru(II) polypyridyl compounds towards their application in anticancer therapy and diagnostics and can open new opportunities for already developed complexes.

Keywords: ruthenium(II) polypyridyl complexes, serum protein, albumin, binding, anticancer activity

Rights & PermissionsPrintExport Cite as

Article Details

(E-pub Abstract Ahead of Print)
DOI: 10.2174/1389203720666190513090851
Price: $95